Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide
| Image |  |
|---|---|
| Description | scientific article published on 22 August 2019 |
| Author/s |
author: Annick Desjardins Mary Lou Affronti Frances McSherry |
| Publication date | August 22, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |